View Older Stories View More Recent Stories

Sep 15, 2021 08:30AM Simulations Plus Releases ADMET Predictor® (X.3)
Sep 8, 2021 08:30AM Simulations Plus to Participate in BofA Securities and Oppenheimer Investor Conferences
Aug 19, 2021 08:30AM Simulations Plus Reports Continued Success in Second Phase of AIDD Collaboration with Large Pharmaceutical Company
Aug 4, 2021 08:36AM Simulations Plus (SLP) Announces NMPA’s Center for Drug Evaluation Adds Licenses of GastroPlus
Aug 4, 2021 08:30AM NMPA’s Center for Drug Evaluation Adds Licenses of GastroPlus®
Jul 12, 2021 04:05PM Simulations Plus Reports Third Quarter Fiscal 2021 Financial Results
Jul 8, 2021 08:30AM Simulations Plus Celebrates 25 Years in Business
Jun 28, 2021 04:15PM Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings Release and Conference Call
Jun 17, 2021 08:30AM Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantitative Systems Pharmacology (QSP) Software for Idiopathic Pulmonary Fibrosis (IPF)
May 27, 2021 08:30AM Simulations Plus to Participate in 18th Annual Craig-Hallum Institutional Investor Conference
May 13, 2021 08:30AM Simulations Plus to Present at 16th Annual Needham Virtual Technology & Media Conference
May 12, 2021 08:30AM Simulations Plus Uplisted to The Nasdaq Global Select Market®
Apr 27, 2021 08:30AM Simulations Plus Releases ADMET Predictor® (X.2)
Apr 20, 2021 08:32AM Simulations Plus (SLP) Announces U.S. FDA Renews Licenses of DILIsym Software
Apr 20, 2021 08:30AM U.S. FDA Renews Licenses of DILIsym Software
Apr 12, 2021 04:05PM Simulations Plus Reports Record Second Quarter Fiscal 2021 Financial Results
Apr 7, 2021 08:30AM Simulations Plus Reports Successful Results from AIDD Collaboration with Large Pharmaceutical Company
Mar 29, 2021 04:05PM Simulations Plus Sets Date for Second Quarter Fiscal Year 2021 Earnings Release and Conference Call
Mar 16, 2021 08:30AM Simulations Plus Forms Scientific Advisory Board for RENAsym Consortium
Mar 11, 2021 08:30AM Simulations Plus Hosts the Inaugural 2021 MIDD+ Scientific Conference with over 50 Model-Informed Drug Development Sessions
Feb 23, 2021 08:30AM Simulations Plus and the University of Pittsburgh Drug Discovery Institute Receive SBIR Grant Funding for Large Molecule Safety Collaboration
Feb 11, 2021 08:30AM Simulations Plus to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Feb 9, 2021 08:30AM Simulations Plus Releases GastroPlus® Version 9.8.1
Feb 2, 2021 08:36AM Simulations Plus (SLP) Enters Agreement with Distributor in China
Feb 2, 2021 08:30AM Simulations Plus Enters Agreement with Distributor in China
Jan 26, 2021 08:30AM Simulations Plus Expands Marketing and Sales Operations in South America Through Partnership with the Institute of Pharmaceutical Sciences
Jan 14, 2021 08:30AM Simulations Plus Awards Infrastructure Improvement Grant to Makerere University Department of Pharmacology and Therapeutics
Jan 12, 2021 08:45AM Simulations Plus to Present at 23rd Annual Needham Virtual Growth Conference
Jan 12, 2021 08:30AM Simulations Plus Enters New Funded Collaboration to Improve Lung Exposure Models for Pulmonary Infection Treatments
Jan 11, 2021 04:05PM Simulations Plus Reports Record First Quarter FY2021 Financial Results
Jan 5, 2021 08:30AM Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus® ACAT™ Model for Oral Absorption of Peptides
Jan 4, 2021 08:30AM Simulations Plus Sets Date for First Quarter Fiscal Year 2021 Earnings Release and Conference Call
Dec 16, 2020 08:30AM Simulations Plus Publishes its Inaugural Environmental, Social and Governance (ESG) Report
Dec 3, 2020 08:30AM DILIsym Services Presents Important DILIsym and NAFLDsym Software Applications at the Virtual AASLD Liver Meeting
Dec 1, 2020 04:16PM Simulations Plus (SLP) Names Industry Veteran Will Frederick as CFO
Dec 1, 2020 04:05PM Simulations Plus Names Industry Veteran Will Frederick as Chief Financial Officer
Nov 16, 2020 04:05PM Simulations Plus Reports FY2020 and Fourth Quarter FY2020 Financial Results
Nov 10, 2020 08:30AM DILIsym Plays Critical Role in Submission to State of California for Common Analgesic Carcinogenicity Risk Assessment
Nov 9, 2020 08:30AM Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2020 Earnings Release and Conference Call
Nov 5, 2020 08:30AM Simulations Plus to Participate in the Credit Suisse Virtual Healthcare Conference
Nov 3, 2020 08:30AM Lixoft Expands MonolixSuite™ in Version 2020R1
Oct 27, 2020 08:30AM First Approved Cancer Treatment for TGCT Included DILIsym Simulations in FDA Review
Oct 20, 2020 08:30AM Simulations Plus Releases GastroPlus® Version 9.8
Oct 13, 2020 08:30AM Simulations Plus Teams Up with the University of Health Sciences and Pharmacy in St. Louis to Secure New Grant Award from the U.S. FDA
Oct 13, 2020 08:30AM Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share
Sep 29, 2020 08:32AM Simulations Plus (SLP) Extends Partnership with Large Pharmaceutical Company to Further Expand High-Throughput PBPK Capabilities in ADMET Predictor
Sep 29, 2020 08:30AM Simulations Plus Extends Partnership with Large Pharmaceutical Company to Further Expand High-Throughput PBPK Capabilities in ADMET Predictor®
Sep 22, 2020 08:30AM Simulations Plus Partners with Large Pharmaceutical Company to Validate AI-Driven Drug Design Capabilities in ADMET Predictor®
Sep 15, 2020 08:30AM Simulations Plus Releases ADMET Predictor® Version 10.0 (APX)
Sep 2, 2020 08:30AM FDA Review of Approved Drug, Ubrogepant, Included DILIsym Simulations
View More Recent Stories View Older Stories